<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1199">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05145543</url>
  </required_header>
  <id_info>
    <org_study_id>17300428</org_study_id>
    <nct_id>NCT05145543</nct_id>
  </id_info>
  <brief_title>Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery</brief_title>
  <official_title>Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic sinusitis (CRS) is a high incidence disease characterized by pus, nasal obstruction,&#xD;
      olfactory disturbance, headache, and other symptoms, lasting for more than 12 weeks, with&#xD;
      severe cases having ocular compression and visual impairment, which can cause cranial, eye,&#xD;
      and lung complications. Chronic sinusitis is a high-risk disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the main concerns about using packing is that the removal is usually very painful and&#xD;
      can be very bothersome. This procedure may even result in syncope by the activation of the&#xD;
      vasovagal reflex system. There have been a few studies suggesting that nasal packs should not&#xD;
      be used because removal from the nose causes serious discomfort and is painful. Many patients&#xD;
      who have undergone nasal surgery report that the removal of the pack was the most painful&#xD;
      part of the experience.&#xD;
&#xD;
      Postoperative pain is an acute inflammatory pain that starts with surgical trauma and ends&#xD;
      with tissue healing. It can be harmful to organ systems by initiating inflamma¬tion through&#xD;
      different mechanisms, and the alleviation of postoperative pain is considered important for&#xD;
      obtaining homeostasis. Pain may initiate atelectasis due to improper coughing, immobilization&#xD;
      may cause thromboembolism and catecholamine discharge may induce cardiovascular side effects&#xD;
      and undesired changes in neuroendocrine or meta¬bolic function&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to first post-operative analgesic request</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>when patient require analgesia</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Endoscopic Sinus Surgery</condition>
  <condition>Fentanyl</condition>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9 NaCl % (Saline) (5 ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group L</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.25 % levobupivacaine (5 ml) will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group LF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>fentanyl plus 0.25 % levobupivacaine (5 ml) will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group LD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexamethasone plus levobupivacaine (5 ml) will be applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline 0.9%</intervention_name>
    <description>0.9 NaCl % (Saline) (5 ml) will be applied</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine Hydrochloride</intervention_name>
    <description>0.25 % levobupivacaine (5 ml) will be applied.</description>
    <arm_group_label>Group L</arm_group_label>
    <arm_group_label>Group LD</arm_group_label>
    <arm_group_label>Group LF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>fentanyl plus 0.25 % levobupivacaine (5 ml) will be applied.</description>
    <arm_group_label>Group LF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone plus levobupivacaine (5 ml) will be applied.</description>
    <arm_group_label>Group LD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • ASA physical status I-II patients&#xD;
&#xD;
          -  scheduled for elective FESS surgery. • Age from 18 to 65 years patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Age&gt;18 and&lt;65 years patients,&#xD;
&#xD;
               -  Previous history of FESS,&#xD;
&#xD;
               -  Patients with sensitivity to anesthetic agents in the study,&#xD;
&#xD;
               -  Patients who will do additional septoplasty or turbinate surgery,&#xD;
&#xD;
               -  Patients with disturbance of blood coagulation, including pro¬thrombin time&#xD;
                  (PT)/partial thromboplastin time (PTT) prolon¬gation, purpura, and spontaneous&#xD;
                  bleeding;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ghada Abo Elfadl, MD</last_name>
    <phone>01005802086</phone>
    <email>ghadafadl77@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut governorate</name>
      <address>
        <city>Assiut</city>
        <zip>715715</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ghada M Aboelfadl, MD</last_name>
      <phone>01005802086</phone>
      <email>ghadafadl77@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Krings JG, Kallogjeri D, Wineland A, Nepple KG, Piccirillo JF, Getz AE. Complications of primary and revision functional endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2014 Apr;124(4):838-45. doi: 10.1002/lary.24401. Epub 2013 Oct 9.</citation>
    <PMID>24122737</PMID>
  </reference>
  <reference>
    <citation>Chaaban MR, Rana N, Baillargeon J, Baillargeon G, Resto V, Kuo YF. Outcomes and Complications of Balloon and Conventional Functional Endoscopic Sinus Surgery. Am J Rhinol Allergy. 2018 Sep;32(5):388-396. doi: 10.1177/1945892418782248. Epub 2018 Jun 27.</citation>
    <PMID>29947260</PMID>
  </reference>
  <reference>
    <citation>Stankiewicz JA, Lal D, Connor M, Welch K. Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience. Laryngoscope. 2011 Dec;121(12):2684-701. doi: 10.1002/lary.21446. Epub 2011 Nov 15.</citation>
    <PMID>22086769</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 26, 2021</study_first_submitted>
  <study_first_submitted_qc>December 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>December 3, 2021</last_update_submitted>
  <last_update_submitted_qc>December 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ghada Mohammed AboelFadl</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>dexamethasone</keyword>
  <keyword>Levobupivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

